Evicenter
Entyvio (vedolizumab) in Ulcerative colitis
Manufacturer
Takeda Pharmaceuticals U.S.A., Inc.
Prescribing information
Entyvio (opens in a new tab)
Questions
37
Last updated

All questions

Access and coverage: Entyvio (vedolizumab) in ulcerative colitis

11 questions · 6 sources

Cost and coverage

What is the price (WAC) of Entyvio?

Note: Wholesale acquisition costs from the Connecticut WAC disclosure form dated November 9, 2026, which the Entyvio HCP site links in its page footer. Each price is for the package size listed beside it. The disclosure lists no price for the prefilled syringe (NDC 64764-107-11).

Is there an Entyvio copay assistance program?

Note: Program terms as captured from the Entyvio HCP patient support page on November 13, 2026; Takeda states it may change or end the program at any time. The maximum is $9,000 per calendar year when a health plan uses a copay maximizer program (see the copay maximizer question).

Does the Entyvio copay program work with copay maximizer or accumulator plans?

Note: Program terms as captured from the Entyvio HCP patient support page on November 13, 2026. The program is for eligible commercially insured patients only; government-insured patients are excluded.

Can Medicare patients use Entyvio copay assistance or patient assistance?

Note: The second passage is an eligibility condition, and the third a patient declaration, of the ENTYVIO Patient Assistance Program application in the EntyvioConnect enrollment form, which applies to patients approved for that program (see the patient assistance question). Terms as captured November 13, 2026.

Is Entyvio covered by commercial insurance?

Note: Manufacturer statement based on Managed Markets Insight & Technology data as of December 2025, as captured November 13, 2026. For the Entyvio Pen, the manufacturer's covered-lives figure includes plans that require biologic step edits. The page gives no share of covered lives and no figure for Medicare or Medicaid.

Access support

Is there an Entyvio patient assistance program?

Note: Eligibility terms from the EntyvioConnect enrollment form linked from the patient support page, as captured November 13, 2026.

Can commercially insured patients get Entyvio free after a coverage denial (Start Program)?

Note: Terms from the EntyvioConnect Terms and Conditions document (US-VED-4379v1.0, dated 06/26), linked from the Entyvio HCP home page, as captured November 13, 2026. The patient support page describes the program as covering insurance delays; the Terms and Conditions require a coverage exclusion, coverage denial, or prior authorization denial.

Does Entyvio have a bridge program for gaps in insurance coverage?

“The Bridge Program provides continuity of care when an eligible ENTYVIO patient experiences a loss of or gap in commercial insurance coverage or authorization. The Bridge Program provides up to 6 months of product at no cost to enrolled patients while they obtain commercial coverage for ENTYVIO. Patients must be currently receiving ENTYVIO therapy and experiencing a gap in or loss of commercial coverage. The Bridge Program is not available to patients who are eligible for federal or state healthcare programs (Medicare, Medicaid, TRICARE, etc.). Patients who experience a Plan Exclusion due to Alternate Funding Program (AFP) involvement are not eligible for the Bridge Program. Patients who have not yet received their first dose of ENTYVIO are not eligible. There is no purchase obligation by virtue of a patient’s participation in the Bridge Program. Free product provided through the Bridge Program is only available through the Bridge Program’s contracted non-commercial Specialty Pharmacy. No claim for reimbursement for product dispensed through the Bridge Program may be submitted to any third-party payer. Benefits provided under the Bridge Program are not transferable. Eligibility will be determined on a case-by-case basis. Takeda reserves the right to change or end the Bridge Program at any time, and other terms and conditions may apply.” (opens the source at this quote in a new tab)

Note: Terms from the EntyvioConnect Terms and Conditions document (US-VED-4379v1.0, dated 06/26), linked from the Entyvio HCP home page, as captured November 13, 2026.

Which specialty pharmacies carry the Entyvio Pen?

Applies to Moderately to severely active ulcerative colitis in adults, subcutaneous maintenance after two intravenous induction doses

Note: From the Specialty Pharmacy Information sheet (US-VED-2383v6.0, dated 05/26) linked from the Entyvio Pen dosing page, as captured November 13, 2026.

Prior authorization

How does prior authorization work for Entyvio and the Entyvio Pen?

Note: From the EntyvioConnect Prior Authorization Checklist linked from the patient support page.

Patient support

What patient support services does EntyvioConnect offer?